Sign up to get updates from us
There are no approved treatments to treat dry macular degeneration – a disease of the eye that can lead to eventual blindness. The standard of care for these patients consists of functional/behavioral training to acclimate the patient to their progressive, incurable vision loss. Lloyd Diamond, CEO of Pixium Vision, is convinced that much more can be done. Thus, the advent of Prima: Pixium’s bionic eye.
